Sarepta Therapeutics (NASDAQ:SRPT)

Top Baird Health Care and Biotech Picks Have Massive Upside Potential

The more disruptive the market is, the more we look for companies that are not affected by the daily sturm and drang of the news cycle because they have supply ...
Read Full Story »

4 Biotechs Making Major Moves on Tuesday

Tuesday was a breakout day for a few biotech companies that saw either huge gains or massive losses. With the markets holding near all-time highs, these companies could move the ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AbbVie, Beyond Meat, Bio-Rad, Dell, HP, Jumia, Nabriva, PG&E, Salesforce, Sarepta and More

Last week's worst one-day sell-off was followed by three straight days of rallies, and the losses have been effectively wiped out. Stocks were indicated to open marginally higher on Tuesday ...
Read Full Story »

Merrill Lynch’s Top Second-Half 2019 Small and Midcap Stock Picks

As the markets have raced to historic highs, it’s important to remember that the so-called FAANG stocks, (Facebook, Apple, Amazon, Netflix and Google) have driven much of the record-breaking performance ...
Read Full Story »

Credit Suisse Best Ideas List Still Has 50% Implied Upside for 8 Stocks

With the three major stock indexes trading at or near all-time highs, many investors are scratching their heads about where to look for new investment ideas at a time when ...
Read Full Story »

Pfizer’s Duchenne Muscular Dystrophy Pain Could Make Sarepta the DMD King

Pfizer Inc. (NYSE: PFE) has released initial clinical data from its Phase 1b gene therapy study for Duchenne muscular dystrophy (DMD). While these results did not necessarily live up to ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Carnival, Caterpillar, Darden Restaurants, Fiserv, KeyCorp, Micron, Phillips 66 and More

The market opened lower this morning after posting an intraday all-time high for the S&P 500 yesterday. Concerns over Iran after allegedly shooting down a U.S. Air Force drone and ...
Read Full Story »

Which Gene Therapy Companies May Be Most Valuable After Spark Therapeutics Buyout

Spark Therapeutics Inc. (NASDAQ: ONCE) shares more than doubled in Tuesday’s session as the result of its pending acquisition. However, the root of the buyout was its gene therapy, which ...
Read Full Story »

Credit Suisse Issues Top Outperform Stock Picks for 2019

Almost every December it seems that investors stop thinking about the prior 11 months and turn their attention to how they want to position their investments for the new year. With ...
Read Full Story »

8 Large Insider Buying Trades That Are Too Big to Ignore

  After a big stock market sell-off and a subsequent snap-back rally, it's always interesting to see how corporate directors are acting toward their own shares. It's no secret ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Chevron, First Data, JD.com, MongoDB, PG&E, Rite Aid, Tilray, Vodafone and More

Stocks were indicated marginally higher on Thursday, but not so much that the direction of the trading day looked set in stone. The major market equity indexes recently hit all-time ...
Read Full Story »

7 Biotech Stocks Insiders Are Loading Up On

Biotechnology stocks have a reputation for being some of the most speculative, most volatile stocks out there. Investors and would-be investors have to stay alert to avoid getting burned. One ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Akamai, Apple, AutoZone, Dropbox, EA, Ford, Kinder Morgan, Pandora, P&G, Shopify and More

The major equity indexes were looking for direction on Wednesday morning ahead of the Federal Reserve's decision on interest rates. Earnings season is still going strong, with dozens of household ...
Read Full Story »

Why Sarepta Shares Are Skyrocketing

Sarepta Therapeutics Inc. (NASDAQ: SRPT) shares skyrocketed on Tuesday after the firm presented positive preliminary results from its midstage Duchenne muscular dystrophy (DMD) trial. Specifically, the results came from Sarepta’s ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AMC, Alkermes, Echostar, Kohls, L Brands, US Bancorp, Sarepta Therapeutics and More

The futures traded just a touch higher Friday morning as the market continued to digest some big gains from the past two weeks. Stocks took off once again yesterday when ...
Read Full Story »